Advertisement
[adinserter block="11" template="Global Header" check="exceptions" ignore="page-type"]
Home »

#VisualAbstract: High-Dose Recombinant Influenza Vaccine is More Effective than Standard-Dose Vaccine in Adults Aged 50 to 64 Years

Dec 22, 2023

ABOUT THE EXPERTS

Advertisement
[adinserter block="6" template="Multi-Media " check="exceptions" ignore="page-type"]